1
|
Strepkos D, Markouli M, Klonou A, Piperi C
and Papavassiliou AG: Insights in the immunobiology of
glioblastoma. J Mol Med (Berl). 98:1–10. 2019. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ahammed Muneer KV, Rajendran VR and K PJ:
Glioma tumor grade identification using artificial intelligent
techniques. J Med Syst. 43:1132019. View Article : Google Scholar : PubMed/NCBI
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and xancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhu Y, Tong Y, Wu J, Liu Y and Zhao M:
Knockdown of LncRNA GHET1 suppresses prostate cancer cell
proliferation by inhibiting HIF-1α/Notch-1 signaling pathway via
KLF2. Biofactors. 45:364–373. 2019. View Article : Google Scholar : PubMed/NCBI
|
7
|
Wang Y, Jiang F, Xiong Y, Cheng X, Qiu Z
and Song R: LncRNA TTN-AS1 sponges miR-376a-3p to promote
colorectal cancer progression via upregulating KLF15. Life Sci.
244:1169362020. View Article : Google Scholar : PubMed/NCBI
|
8
|
Fei F, He Y, He S, He Z, Wang Y, Wu G and
Li M: LncRNA SNHG3 enhances the malignant progress of glioma
through silencing KLF2 and p21. Biosci Rep. 38:BSR201804202018.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Liao Y, Shen L, Zhao H, Liu Q, Fu J, Guo
Y, Peng R and Cheng L: LncRNA CASC2 interacts with miR-181a to
modulate glioma growth and resistance to TMZ through PTEN pathway.
J Cell Biochem. 118:1889–1899. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Tang F, Wang H, Chen E, Bian E, Xu Y, Ji
X, Yang Z, Hua X, Zhang Y and Zhao B: LncRNA-ATB promotes
TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK
pathway. J Cell Physiol. 234:23302–23314. 2019. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ding M, Liu Y, Liao X, Zhan H, Liu Y and
Huang W: Enhancer RNAs (eRNAs): New insights into gene
transcription and disease treatment. J Cancer. 9:2334–2340. 2018.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Zaheer U, Faheem M, Qadri I, Begum N,
Yassine HM, Al Thani AA and Mathew S: Expression profile of
MicroRNA: An emerging hallmark of cancer. Curr Pharm Des.
25:642–653. 2019. View Article : Google Scholar : PubMed/NCBI
|
13
|
Hu G, Liu N, Wang H, Wang Y and Guo Z:
LncRNA LINC01857 promotes growth, migration, and invasion of glioma
by modulating miR-1281/TRIM65 axis. J Cell Physiol.
234:22009–22016. 2019. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhao H, Peng R, Liu Q, Liu D, Du P, Yuan
J, Peng G and Liao Y: The lncRNA H19 interacts with miR-140 to
modulate glioma growth by targeting iASPP. Arch Biochem Biophys.
610:1–7. 2016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhang Q, Wang G, Xu L, Yao Z and Song L:
Long non-coding RNA LINC00473 promotes glioma cells proliferation
and invasion by impairing miR-637/CDK6 axis. Artif Cells Nanomed
Biotechnol. 47:3896–3903. 2019. View Article : Google Scholar : PubMed/NCBI
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42(D1): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Dang Y, Wei X, Xue L, Wen F, Gu J and
Zheng H: Long non-coding RNA in glioma: Target miRNA and signaling
pathways. Clin Lab. 64:887–894. 2018. View Article : Google Scholar : PubMed/NCBI
|
19
|
Lin C, Zhang S, Wang Y, Wang Y, Nice E,
Guo C, Zhang E, Yu L, Li M, Liu C, et al: Functional role of a
novel long noncoding RNA TTN-AS1 in esophageal squamous cell
carcinoma progression and metastasis. Clin Cancer Res. 24:486–498.
2018. View Article : Google Scholar : PubMed/NCBI
|
20
|
Cui Z, Luo Z, Lin Z, Shi L, Hong Y and Yan
C: Long non-coding RNA TTN-AS1 facilitates tumorigenesis of
papillary thyroid cancer through modulating the miR-153-3p/ZNRF2
axis. J Gene Med. 21:e30832019. View
Article : Google Scholar : PubMed/NCBI
|
21
|
Li S, Liu F, Pei Y, Wang W, Zheng K and
Zhang X: Long noncoding RNA TTN-AS1 enhances the malignant
characteristics of osteosarcoma by acting as a competing endogenous
RNA on microRNA-376a thereby upregulating dickkopf-1. Aging (Albany
NY). 11:7678–7693. 2019.PubMed/NCBI
|
22
|
Xu Y, Han YF, Ye B, Zhang YL, Dong JD, Zhu
SJ and Chen J: miR-27b-3p is involved in doxorubicin resistance of
human anaplastic thyroid cancer cells via targeting peroxisome
proliferator-activated receptor gamma. Basic Clin Pharmacol
Toxicol. 123:670–677. 2018. View Article : Google Scholar : PubMed/NCBI
|
23
|
Liu L, Hu J, Yu T, You S, Zhang Y and Hu
L: miR-27b-3p/MARCH7 regulates invasion and metastasis of
endometrial cancer cells through Snail-mediated pathway. Acta
Biochim Biophys Sin (Shanghai). 51:492–500. 2019. View Article : Google Scholar : PubMed/NCBI
|
24
|
Zhang R, Li JB, Yan XF, Jin K, Li WY, Xu
J, Zhao J, Bai JH and Chen YZ: Increased EWSAT1 expression promotes
cell proliferation, invasion and epithelial-mesenchymal transition
in colorectal cancer. Eur Rev Med Pharmacol Sci. 22:6801–6808.
2018.PubMed/NCBI
|
25
|
Wang M, Qiu Y, Zhang R, Gao L, Wang X, Bi
L and Wang Y: MEHP promotes the proliferation of oral cancer cells
via down regulation of miR-27b-5p and miR-372-5p. Toxicol In Vitro.
58:35–41. 2019. View Article : Google Scholar : PubMed/NCBI
|
26
|
Liang H, Ai-Jun J, Ji-Zong Z, Jian-Bo H,
Liang Z, Yong-Xiang Y and Chen Y: Clinicopathological significance
of miR-27b targeting Golgi protein 73 in patients with
hepatocellular carcinoma. Anticancer Drugs. 30:186–194. 2019.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Chen Y, Zhang B, Jin Y, Wu Q and Cao L:
MiR-27b targets PI3K p110α to inhibit proliferation and migration
in colorectal cancer stem cell. Am J Transl Res. 11:5988–5997.
2019.PubMed/NCBI
|
28
|
Hong D, Fritz AJ, Gordon JA, Tye CE, Boyd
JR, Tracy KM, Frietze SE, Carr FE, Nickerson JA, Van Wijnen AJ, et
al: RUNX1-dependent mechanisms in biological control and
dysregulation in cancer. J Cell Physiol. 234:8597–8609. 2019.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Chen K and Pan G: Dysregulation of
microRNA-106a-5p-RUNX1 axis associates with clinical progression
and prognosis of osteosarcoma patients. Pathol Res Pract.
215:1526862019. View Article : Google Scholar : PubMed/NCBI
|
30
|
Fu Y, Sun S, Man X and Kong C: Increased
expression of RUNX1 in clear cell renal cell carcinoma predicts
poor prognosis. PeerJ. 7:e78542019. View Article : Google Scholar : PubMed/NCBI
|
31
|
Keita M, Bachvarova M, Morin C, Plante M,
Gregoire J, Renaud MC, Sebastianelli A, Trinh XB and Bachvarov D:
The RUNX1 transcription factor is expressed in serous epithelial
ovarian carcinoma and contributes to cell proliferation, migration
and invasion. Cell Cycle. 12:972–986. 2013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Zhou T, Luo M, Cai W, Zhou S, Feng D, Xu C
and Wang H: Runt-related transcription factor 1 (RUNX1) promotes
TGF-β-induced renal ttubular epithelial-to-mesenchymal transition
(EMT) and renal fibrosis through the PI3K subunit p110δ.
EBioMedicine. 31:217–225. 2018. View Article : Google Scholar : PubMed/NCBI
|
33
|
Alonso-Alconada L, Muinelo-Romay L,
Madissoo K, Diaz-Lopez A, Krakstad C, Trovik J, Wik E, Hapangama D,
Coenegrachts L, Cano A, et al: ENITEC Consortium: Molecular
profiling of circulating tumor cells links plasticity to the
metastatic process in endometrial cancer. Mol Cancer. 13:2232014.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Scheitz CJF, Lee TS, McDermitt DJ and
Tumbar T: Defining a tissue stem cell-driven Runx1/Stat3 signalling
axis in epithelial cancer. EMBO J. 31:4124–4139. 2012. View Article : Google Scholar : PubMed/NCBI
|